PRECIGEN, INC. - Common Stock (PGEN)

CUSIP: 74017N105

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock
Shares outstanding
353,007,843
Total 13F shares
136,011,489
Share change
+22,261,196
Total reported value
$568,542,925
Put/Call ratio
2.7%
Price per share
$4.18
Number of holders
179
Value change
+$96,374,703
Number of buys
107
Number of sells
51

Security key

74017N105

Report period

Q4 2025

Institutions

179

Top holders

10

Top shareholders of PGEN - PRECIGEN, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Patient Capital Management, LLC
13D/G 13F
Company
10%
36,006,800
$150,508,424 -$38,525,651 31 Dec 2025
William H. Miller III
13D/G
William H. Miller III Living Trust dated April 17, 2017
9.2%
34,051,925
$154,936,259 $0 26 Jun 2025
TANG CAPITAL MANAGEMENT LLC
13F
Company
3.5%
12,400,000
$40,796,000 30 Sep 2025
13F
BlackRock, Inc.
13F
Company
3.4%
12,149,955
$39,973,352 30 Sep 2025
13F
VANGUARD GROUP INC
13F
Company
2.5%
8,942,285
$29,420,118 30 Sep 2025
13F
STATE STREET CORP
13F
Company
1.3%
4,489,827
$14,771,531 30 Sep 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.1%
3,848,738
$12,665,203 30 Sep 2025
13F
IRIDIAN ASSET MANAGEMENT LLC/CT
13F
Company
1%
3,666,946
$12,064,252 30 Sep 2025
13F
Point72 Asset Management, L.P.
13F
Company
0.78%
2,741,066
$9,018,107 30 Sep 2025
13F
Occam Crest Management LP
13F
Company
0.76%
2,697,400
$8,874,446 30 Sep 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.76%
2,695,831
$8,869,284 30 Sep 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.71%
2,505,992
$8,244,713 30 Sep 2025
13F
Parkman Healthcare Partners LLC
13F
Company
0.6%
2,101,715
$6,914,642 30 Sep 2025
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
0.58%
2,042,510
$6,719,858 30 Sep 2025
13F
MORGAN STANLEY
13F
Company
0.56%
1,981,644
$6,519,612 30 Sep 2025
13F
NORTHERN TRUST CORP
13F
Company
0.39%
1,375,964
$4,526,922 30 Sep 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.36%
1,259,913
$4,145,114 30 Sep 2025
13F
Diametric Capital, LP
13F
Company
0.28%
974,228
$3,205,210 30 Sep 2025
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.24%
856,593
$2,818,188 30 Sep 2025
13F
Boxer Capital Management, LLC
13F
Company
0.24%
850,000
$2,796,500 30 Sep 2025
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.24%
846,000
$2,783,340 30 Sep 2025
13F
Nuveen, LLC
13F
Company
0.23%
798,807
$2,628,075 30 Sep 2025
13F
Corient Private Wealth LLC
13F
Company
0.23%
797,571
$2,624,009 30 Sep 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.22%
779,558
$2,564,746 30 Sep 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.22%
760,395
$2,501,699 30 Sep 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.21%
733,487
$2,413,172 30 Sep 2025
13F
Informed Momentum Co LLC
13F
Company
0.19%
677,370
$2,192,130 30 Sep 2025
13F
GMT CAPITAL CORP
13F
Company
0.19%
668,830
$2,200,451 30 Sep 2025
13F
FRANKLIN RESOURCES INC
13F
Company
0.19%
667,178
$2,195,016 30 Sep 2025
13F
LexAurum Advisors, LLC
13F
Company
0.19%
666,038
$2,191,265 30 Sep 2025
13F
UBS Group AG
13F
Company
0.18%
630,604
$2,074,688 30 Sep 2025
13F
BARCLAYS PLC
13F
Company
0.16%
555,856
$1,828,766 30 Sep 2025
13F
Lansing Street Advisors
13F
Company
0.15%
547,038
$1,799,755 30 Sep 2025
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.15%
522,181
$1,717,975 30 Sep 2025
13F
MARSHALL WACE, LLP
13F
Company
0.12%
411,794
$1,354,802 30 Sep 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.12%
406,403
$1,337,066 30 Sep 2025
13F
Bank of New York Mellon Corp
13F
Company
0.11%
381,619
$1,255,525 30 Sep 2025
13F
Cetera Investment Advisers
13F
Company
0.11%
376,721
$1,239,412 30 Sep 2025
13F
PRELUDE CAPITAL MANAGEMENT, LLC
13F
Company
0.08%
269,511
$886,691 30 Sep 2025
13F
CIBC Private Wealth Group LLC
13F
Company
0.07%
257,465
$847,060 30 Sep 2025
13F
RHUMBLINE ADVISERS
13F
Company
0.06%
215,769
$709,874 30 Sep 2025
13F
SIMPLEX TRADING, LLC
13F
Company
0.06%
214,102
$704,000 30 Sep 2025
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.05%
193,860
$637,799 30 Sep 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
0.05%
188,131
$683,154 30 Sep 2025
13F
Creative Planning
13F
Company
0.05%
172,556
$567,710 30 Sep 2025
13F
LPL Financial LLC
13F
Company
0.05%
163,424
$537,665 30 Sep 2025
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.04%
153,520
$505,081 30 Sep 2025
13F
Mill Creek Capital Advisors, LLC
13F
Company
0.04%
150,000
$493,500 30 Sep 2025
13F
OMERS ADMINISTRATION Corp
13F
Company
0.04%
148,000
$486,920 30 Sep 2025
13F
Voleon Capital Management LP
13F
Company
0.04%
146,664
$482,525 30 Sep 2025
13F

Institutional Holders of PRECIGEN, INC. - Common Stock (PGEN) as of Q4 2025

As of 31 Dec 2025, PRECIGEN, INC. - Common Stock (PGEN) was held by 179 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 136,011,489 shares. The largest 10 holders included Patient Capital Management, LLC, BlackRock, Inc., Point72 Asset Management, L.P., STATE STREET CORP, VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, Diametric Capital, LP, and Driehaus Capital Management LLC. This page lists 179 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
165
Q4 2025 holders
179
Holder diff
14
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .